While the Bharat Biotech (Covaxin) facility is being established in Malur of Kolar district, Shilpa Biologicals Pvt Ltd (SBPL) is expected to manufacture Sputnik V from its R&D facility in Dharwad.
As the country is affected by a severe shortage of vaccines, Karnataka is expected to participate in institutions involved in producing two Covid vaccines - Covaxin and Sputnik V.
While the Barat Biotech (Covaxin) facility is under construction in Malur in the Kolar region, Shilpa Biologicals Pvt Ltd (SBPL) is expected to produce Sputnik V at its R&D facility in Dharwad.
According to Karnataka Health Minister K Sudhakar, Bharat Biotech has expressed confidence in producing about 5 doses of crore Covaxin per month by the end of August, starting with an average of 1 crore per month at the end of June.
“They have assured me that their Malur area in Kolar will be able to produce crore 1 vaccine by the end of June. By the end of July, it will have been upgraded to 3 kilograms, as their target for production at the end of August is 4 to 5 crore vaccines, ”Sudhakar said on Monday. He added that he had similarly discussed the video conference with the founder of Bharat Biotech Krishna Ella, his daughter Jala Ella, and the team.
He added that the state was looking for people to be vaccinated first. "The company has confirmed that they will provide the drugs in Karnataka in the beginning," Sudhakar said.
Meanwhile, the SBPL has stated in a regulatory document that its intended production of the double vector Sputnik V in the first 12 months at a cost of $ 50 million from the start of commercial production.
SBPL is a wholly owned subsidiary of the drug company Shipa Medicare, which according to the company, has entered into a three-year agreement with Dr. Reddy's Laboratories to manufacture and supply the Sputnik V vaccine from its integrated biologics.
"The intended production of the Sputnik V dual vector in the first 12 months is 50 million estimates (50 million for part 1 and 50 million for part 2), from the first day of commercial production," the company said in its file. The transfer of Sputnik technology is expected to be facilitated by Dr. Reddy's as a company.
To date, Karnataka has included 1,12 crore vaccine doses of its first 87.43 lakhs and another 25.17 lakh second doses used to infect people from all significant age groups and ages, from January 16 this year.
According to figures released by the Department of Health, while 74.34 lakh people aged 45 and over received their first jab, only 18.60 lakhs were added for the second dose, on Monday (May 17). More than 1.17 lakh people from the age group of 18 to 44, have so far, received the first dose of vaccine so far.
Posts
